These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33152476)

  • 1. Recent advances and prospects in gemcitabine drug delivery systems.
    Paroha S; Verma J; Dubey RD; Dewangan RP; Molugulu N; Bapat RA; Sahoo PK; Kesharwani P
    Int J Pharm; 2021 Jan; 592():120043. PubMed ID: 33152476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
    Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
    J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmonic nanocarrier grid-enhanced Raman sensor for studies of anticancer drug delivery.
    Kurzątkowska K; Santiago T; Hepel M
    Biosens Bioelectron; 2017 May; 91():780-787. PubMed ID: 28142123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine's Drug Conjugates on Cancer Therapy.
    Dyawanapelly S; Kumar A; Chourasia MK
    Crit Rev Ther Drug Carrier Syst; 2017; 34(1):63-96. PubMed ID: 28322141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology for delivery of gemcitabine to treat pancreatic cancer.
    Birhanu G; Javar HA; Seyedjafari E; Zandi-Karimi A
    Biomed Pharmacother; 2017 Apr; 88():635-643. PubMed ID: 28142120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.
    Chen Z; Zheng Y; Shi Y; Cui Z
    Int J Nanomedicine; 2018; 13():319-336. PubMed ID: 29391792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.
    Pooja D; Panyaram S; Kulhari H; Reddy B; Rachamalla SS; Sistla R
    Int J Biol Macromol; 2015 Sep; 80():48-56. PubMed ID: 26093321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine.
    Santiago T; DeVaux RS; Kurzatkowska K; Espinal R; Herschkowitz JI; Hepel M
    Int J Nanomedicine; 2017; 12():7763-7776. PubMed ID: 29123391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
    Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
    Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells.
    Kulhari H; Pooja D; Kota R; Reddy TS; Tabor RF; Shukla R; Adams DJ; Sistla R; Bansal V
    Mol Pharm; 2016 May; 13(5):1491-500. PubMed ID: 26930230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells.
    Trabulo S; Aires A; Aicher A; Heeschen C; Cortajarena AL
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1597-1605. PubMed ID: 28161480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.